B6-015 Myositis Flashcards

1
Q

what would you expect to see on EMG in a case of inflammatory myopathy?

A

similar to normal with lower amplitude waves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

at three years post diagnosis, patients treated with [….] had better functional outcomes and required less prednisone maintenance therapy

A

combination therapy

prednisone + azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

because young patients with myositis require long term steroid therapy, […] should be added to their regime

A

steroid sparing agent (azathioprine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

most appropriate treatment for infectious myositis

A

IV antibiotics and consider surgical drainage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

[….] is often associated with malignancy

A

dermatomyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

in women, there is an association of dermatomyositis and […]

A

ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what would you expect to see on muscle biopsy in a patient with dermatomyositis?

A

-increased complement activation -> complement deposition on capillaries
-microvasulopathy
-perifasicular atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

patients presenting with inflammatory myopathies and severe complications should receive […]

A

IVIG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

features consistent with long term steroid use

A

moon facies
weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

most common neuromuscular disorder in the world

A

chronic alcohol related neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2 most common types of painless myopathy

A

alcohol and steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

in chronic alcohol related neuropathy, CK levels are typically normal, but
[…] will result in a rapid increase

A

ingestion of alcohol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A

normal skeletal muscle

**note: uniform connective tissue and nuclei at edges

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

distinguishing feature of myocardium

A

intercalated disc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A

normal myocardium

**note:1-2 centrally located nuclei, multiple mitochondria, intercalated discs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

damage to myofibers directly

A

myopathic injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

injury that disrupts muscle innervation

A

neurogenic injury

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

name some expected skin findings of dermatomyositis

A

-telangiectasias
-heliotrope rash
-erythema around nail beds, elbows, knees
-tight, shiny, red skin
-maybe pressure point ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

upregulation of MHC-1 in myofibers causes an increased expression of ICAM1

A

dermatomyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

heliotrope rash and Gottron papules are associated with what autoantibody?

A

anti-Mi2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

interstitial lung disease and nonerosive arthritis are associated with what autoantibody?

A

anti-Jo1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

patients with what autoantibody should not receive methotrexate?

A

anti-Jo1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

paraneoplastic and juvenille myositis cases are associated with what autoantibody?

A

anti-P155/P140

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CD8 positive T cells are prominent in inflammatory infiltrate

A

polymyositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
on EMG, fewer motor units and increased amplitude indicates
neurogenic lesion
26
on EMG, normal number of motor units with decreased amplitude indicates
myopathic lesion
27
most common acquired disorder in patient over 50 years
sporadic inclusion body myositis
28
weakness of distal muscles
sporadic inclusion body myositis
29
weakness of wrist, finger flexor muscle, and ankle are most common features
sporadic inclusion body myositis
30
asymmetrical, non-dominant side affected
sporadic inclusion body myositis
31
dysphagia is more common with
sporadic inclusion body myositis
32
vacuoles in muscle
sporadic inclusion body myositis
33
distribution of weakness for polymyositis
proximal, symmetric
34
sporadic inclusion body myositis is more common in [.males/females]
males
35
what is the typical age of onset of sporadic inclusion body myositis?
over 50
36
what is the typical onset of sporadic inclusion body myositis?
insidious
37
what is the distribution of weakness associated with sporadic inclusion body myositis?
asymmetric and distal
38
what is the expected CK levels in sporadic inclusion body myositis?
normal or less than 10x normal
39
inflammation, rimmed vacuoles, inclusions
sporadic inclusion body myositis
40
is sporadic inclusion body myositis associated with a good response to therapy?
no
41
is polymyositis more common in males or females?
females
42
what is the typical age of onset of polymyositis?
under 50
43
what is the typical onset of polymyositis?
acute, rapid
44
what is the expected CK levels in polymyositis?
greater than 10x normal
45
biopsy shows inflammation and fiber necrosis
polymyositis
46
does polymyositis generally respond to therapy?
yes
47
associated with anti-SRP
immune mediated necrotizing myopathy
48
associated with malignancy, statin treatment, or viral infection
immune mediated necrotizing myopathy
49
weakness is proximal and severe with CK levels over 3000
immune mediated necrotizing myopathy
50
scattered necrotic fibers with macrophage infiltration and regenerating fibers
immune mediated necrotizing myopathy
51
manifestation of sarcoidosis
granulomatous myositis
52
multinucleated giant cells of the Langhans type with peripherally located nuclei
granulomatous myositis
53
first line treatment for myositis
glucocorticoid
54
inhibits dyhyrofolate reductase
methotrexate
55
advantage of methotrexate over azathioprine
once a week administration
56
treatment for patients with severe life-threatening weakness such as dysphagia
IVIG
57
targets CD20 positive B cells
rituximab
58
promising treatment for recurrent and resistant dematomyositis and polymyositis
rituximab
59
antimalarial that is 70% effective in controlling skin disease
hydroxychloroquine
60
perifasicular atrophy
dermatomyositis
61
CD 4+ T cells
dermatomyositis
62
CD 8+ T cells
polymyositis
63
endomysial infiltration of lymphocytes
polymyositis
64
perimysial infiltration with perifasicular atrophy on biopsy
dermatomyositis
65
endomysial infiltration with necrotic fibers seen on biopsy
polymyositis